Oramed Pharmaceuticals Inc. (TLV: ORMP)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
877.00
-9.50 (-1.07%)
Dec 22, 2024, 3:49 PM IDT

Oramed Pharmaceuticals Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 Dec '20 2019 - 2015
Market Capitalization
3483361,6551,6922,051355
Upgrade
Market Cap Growth
-7.77%-79.72%-2.19%-17.53%477.70%28.87%
Upgrade
Enterprise Value
-175-331,0941,3821,810214
Upgrade
Last Close Price
8.748.2038.8340.8063.3013.77
Upgrade
PE Ratio
20.9916.87----
Upgrade
PS Ratio
-69.54174.08200.54236.7340.73
Upgrade
PB Ratio
0.640.573.113.265.49-
Upgrade
P/TBV Ratio
0.640.573.103.275.53-
Upgrade
EV/Sales Ratio
--115.15163.83208.8724.59
Upgrade
EV/FCF Ratio
5.93-----
Upgrade
Debt / Equity Ratio
0.000.320.010.000.00-
Upgrade
Asset Turnover
-0.010.02-0.03-
Upgrade
Quick Ratio
26.993.0527.1019.8514.09-
Upgrade
Current Ratio
27.083.0627.3420.0814.27-
Upgrade
Return on Equity (ROE)
2.89%3.24%-23.77%--30.78%-
Upgrade
Return on Assets (ROA)
-4.12%-5.16%-14.95%--17.54%-
Upgrade
Return on Capital (ROIC)
-4.29%-5.38%-15.90%--20.19%-
Upgrade
Earnings Yield
4.49%5.93%-7.77%-6.44%-3.48%-19.89%
Upgrade
FCF Yield
-7.97%-11.32%-6.04%-6.14%-3.37%-23.31%
Upgrade
Buyback Yield / Dilution
-2.51%-4.02%-5.08%-30.36%-16.71%-18.81%
Upgrade
Total Shareholder Return
-2.51%-4.02%-5.08%-30.36%-16.71%-18.81%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.